-New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients with Idiopathic Pulmonary Fibrosis

Media coverage

• Title	-New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients with Idiopathic Pulmonary Fibrosis
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	20/05/24
  Persons	Michael Maher

• Title	-New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients with Idiopathic Pulmonary Fibrosis
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	20/05/24
  Persons	Michael Maher